Page 1 of Clinical Trials for BZL Biologics [SPONSOR-COLLABORATORS], 1 Total Matches
- 1CompletedPhase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2Last Updated: January 19, 2007Condition(s): Prostatic Neoplasms
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=BZL+Biologics
